Independent fund research. Built on SEC filings.

How we research funds

Money market fund · Money Market · Morgan Stanley

Government Securities Portfolio Advisory Class (MVAXX)

Ticker MVAXX ·

Expense ratio
0.45%$45/yr per $10k
5-yr return
+2.9%annualized
1-yr return
+3.9%as of Dec 2025

Bottom line

Is MVAXX a good fund? The bottom line

MVAXX is the Advisory Class share class of Government Securities Portfolio, a money market fund from Morgan Stanley.

Its expense ratio is 0.45% — about $45 a year on every $10,000 invested, more expensive than 72% of money market funds we track.

It returned +3.9% over one year, +2.9% a year over five years, +1.8% a year over ten (as of Dec 31, 2025, per its prospectus).

What to watch

  • Expensive for its category (0.45%)

Updated Nov 19, 2026

What MVAXX invests in

The Government Securities Portfolio (the Fund) seeks preservation of capital, daily liquidity and maximum current income.

The Fund has adopted a policy to invest substantially all of its assets in U.S. Treasury obligations and certain U.S. government securities, the interest from which is generally exempt from state income taxation, and, accordingly, qualifies as a government money market fund under federal regulations. The Fund is permitted to hold a portion of its assets in cash. A government money market fund is a money market fund that invests at least 99.5% of its total assets in cash, securities issued or guaranteed by the United States or certain U.S. government agencies or instrumentalities and/or repurchase agreements that are collateralized fully by the foregoing. A government money market fund is exempt from requirements that permit and, under certain circumstances, require money market funds to impose a liquidity fee on redemptions. In selecting investments, the Adviser seeks to maintain the…

From the fund's prospectus (filed Feb 27, 2026).

MVAXX performance

Fund calendar-year total returns, 2016–2025 2016: +0.0%; 2017: +0.5%; 2018: +1.4%; 2019: +1.8%; 2020: +0.3%; 2021: +0.0%; 2022: +1.3%; 2023: +4.7%; 2024: +4.9%; 2025: +3.9% +0% 2016 +0% 2017 +1% 2018 +2% 2019 +0% 2020 +0% 2021 +1% 2022 +5% 2023 +5% 2024 +4% 2025
Fund gain (+)
Average annual total returns
1 yr5 yr10 yr
MVAXX+3.9%+2.9%+1.8%
Money Market median+4.1%+3.0%+1.9%

Source: Fund prospectus, as of Dec 31, 2025

Full MVAXX performance history →

What MVAXX costs

On a $10,000 investment, MVAXX's 0.45% expense ratio costs about $45 a year. The prospectus estimates $601 in total costs over 10 years (assuming 5% annual returns). The median money market fund charges 0.32%.

See the full MVAXX fee table →

Alternatives to MVAXX

More funds like MVAXX →

MVAXX FAQ

What is the expense ratio of MVAXX?
MVAXX's expense ratio is 0.45%, which works out to about $45 a year for every $10,000 invested. The prospectus estimates total costs of $601 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is MVAXX a good investment?
It depends on your goals, but the data points to: expensive for its category (0.45%). This is general information, not personalized advice.
What is MVAXX's 5-year return?
MVAXX returned +2.9% a year over the five years ending Dec 31, 2025, and +1.8% a year over ten years. Past performance does not guarantee future results.
Who manages MVAXX?
MVAXX is offered by Morgan Stanley through Morgan Stanley Institutional Liquidity Funds.